Search results
Aeglea (AGLE) Down on Corporate Restructuring, CEO Steps Down
Zacks via Yahoo Finance· 2 years agoAeglea (AGLE) announces a corporate restructuring plan to prioritize the development of AGLE-177 for...
Aeglea (AGLE) Soars 329% on Acquiring Spyre Therapeutics
Zacks via Yahoo Finance· 11 months agoAeglea's (AGLE) shares surge as it acquires Spyre Therapeutics, a private company that focuses on...
Aeglea BioTherapeutics (AGLE) Seeks EU Nod for ARG1-D Treatment
Zacks via Yahoo Finance· 2 years agoAeglea BioTherapeutics (AGLE) seeks a nod for its lead candidate, pegzilarginase, for treating...
Aeglea (AGLE) Down on RTF Letter from FDA for Rare Disease Drug
Zacks via Yahoo Finance· 2 years agoAeglea (AGLE) gets a Refusal to File letter from the FDA related to the biologics license...
Aeglea Biotherapeutics (AGLE) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAeglea (AGLE) delivered earnings and revenue surprises of 20.83% and 72.38%, respectively, for the...
Aeglea (AGLE) Plunges 26% After Rare Disorder Drug Study Fails
Zacks via Yahoo Finance· 1 year agoAeglea BioTherapeutics (AGLE) announces failure to meet goals in the phase I/II study of...
Even after rising 85% this past week, Aeglea BioTherapeutics (NASDAQ:AGLE) shareholders are still...
Simply Wall St. via Yahoo Finance· 2 years agoOver the last month the Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) has been much stronger than...
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) insiders placed bullish bets worth US$695k in the last 12...
Simply Wall St. via Yahoo Finance· 1 year agoGenerally, when a single insider buys stock, it is usually not a big deal. However, when several...
Having purchased US$1.8m worth of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) stock, the recent 53%...
Simply Wall St. via Yahoo Finance· 2 years agoInsiders who bought US$1.8m worth of Aeglea BioTherapeutics, Inc.'s (NASDAQ:AGLE) stock at an...
Aeglea Bio Feels FDA Refusal Pinch, Cuts Workforce, Shifts Pipeline Focus
Benzinga via Yahoo Finance· 2 years agoAeglea BioTherapeutics Inc (NASDAQ: AGLE) announced a leadership transition and corporate...